Doctors prescribing weight loss drug not yet approved by FDA, CBS News investigation finds
Summary
The drug retatrutide, which is still being tested and has not received approval from the U.S. Food and Drug Administration (FDA), is being prescribed by some doctors for weight loss. This drug is often called "Ozempic on steroids," but it may have serious side effects.Key Facts
- Retatrutide is a weight loss drug currently in clinical trials and has not been approved by the FDA.
- Some doctors are prescribing retatrutide despite it not being approved.
- Retatrutide has been compared to Ozempic but is considered stronger.
- The safety and side effects of retatrutide are not fully known yet.
- CBS News conducted an investigation that revealed these prescribing practices.
- The FDA approval process is important to ensure drugs are safe and effective.
- Patients using unapproved drugs may face health risks due to unknown effects.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.